SERMs and the uterus;SERMs et utérus

Annales de Medecine Interne

Volumn 154, Issue 2, 2003, Pages 103-108

  Touraine, Philippe ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Antiestrogens; Cancer; Endometrium; Raloxifen; SERM; Tamoxifen; Uterus

Indexed keywords

RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; ANTIESTROGEN;

BREAST; CANCER HORMONE THERAPY; CELL PROLIFERATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG MARKETING; DRUG MECHANISM; DRUG TARGETING; ENDOMETRIUM; ESTROGEN ACTIVITY; HUMAN; OSTEOPOROSIS; UTERUS TUMOR; CHEMICALLY INDUCED DISORDER; FEMALE; PATHOLOGY; REVIEW; UTERUS; UTERUS CANCER;

ESTROGEN ANTAGONISTS; FEMALE; HUMANS; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; UTERINE NEOPLASMS; UTERUS;

EID: 0041319497     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. SILFEN SL, CIACCIA AV, BRYANT HU: Selective estrogen receptor modulators: tissue selectivity and differential uterine effects. Climateric 1999; 2: 268-83.
2. WHITE I: Antiestrogenic drugs and endometrial cancers. Toxicol Lett 2001; 120: 21-9.
3. TOURAINE P, DRIGUEZ PA, CARTIER I, YANEVA H, KUTTENN F, MAUVAIS-JARVIS P: Lack of induction of endometrial hyperplasia with tamoxifen. Lancet 1995; 345: 254-5.
4. DAVIES GC, HUSTER WJ, LU Y, PLOUFFE L, LAKSHMANNA M: Adverse events reported by postmenopausal women in controlled trials with raloxifene. Obstet Gynecol 1999; 93: 558-65.
5. COHEN FJ, WATTS S, SHAH A, AKERS R, PLOUFFE L: Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60. Obstet Gynecol 2000; 95: 104-10.
6. CUMMINGS SR, ECKERT S, KRUEGER KA, GRADY D, POWLES TJ, CAULEY JA, et al.: The effect of raloxifen on risk of breast cancer in postmenopausal women. JAMA 1999; 281: 2189-97.
7. PALOMBA S, SAMMARTINO A, DICARLO C, AFFINITO P, ZULLO F, NAPPI C: Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women. Fertil Steril 2001; 76: 38-43.
8. PALOMBO S, ORIO F, MORELLI M, RUSSO T, PELLICANO M, ZUPI E, et al.: Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. J Clin Endocrinol Metab 2002; 87: 3603-8.